BARALDI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 8.993
NA - Nord America 5.358
AS - Asia 2.527
SA - Sud America 406
AF - Africa 67
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 5
Totale 17.388
Nazione #
IT - Italia 6.521
US - Stati Uniti d'America 5.225
GB - Regno Unito 1.016
SG - Singapore 817
CN - Cina 553
VN - Vietnam 316
HK - Hong Kong 310
BR - Brasile 303
FR - Francia 273
SE - Svezia 194
DE - Germania 187
NL - Olanda 170
RU - Federazione Russa 127
IN - India 82
CH - Svizzera 74
KR - Corea 74
UA - Ucraina 70
FI - Finlandia 66
TR - Turchia 64
ID - Indonesia 59
CA - Canada 55
MX - Messico 52
JP - Giappone 46
ES - Italia 45
PL - Polonia 42
AR - Argentina 40
BD - Bangladesh 40
BG - Bulgaria 40
IE - Irlanda 35
AU - Australia 31
ZA - Sudafrica 21
IQ - Iraq 19
AE - Emirati Arabi Uniti 17
EC - Ecuador 17
EG - Egitto 17
IR - Iran 17
BE - Belgio 16
PK - Pakistan 16
TW - Taiwan 16
AT - Austria 15
PH - Filippine 14
CO - Colombia 13
MY - Malesia 11
NO - Norvegia 11
DK - Danimarca 10
CR - Costa Rica 9
CZ - Repubblica Ceca 9
HU - Ungheria 9
LT - Lituania 9
CL - Cile 8
GR - Grecia 8
AL - Albania 7
IL - Israele 7
JO - Giordania 7
PT - Portogallo 7
DZ - Algeria 6
NP - Nepal 6
PY - Paraguay 6
TN - Tunisia 6
UY - Uruguay 6
BY - Bielorussia 5
KG - Kirghizistan 5
MA - Marocco 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
KE - Kenya 4
RS - Serbia 4
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
HR - Croazia 3
JM - Giamaica 3
MD - Moldavia 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
CU - Cuba 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MT - Malta 2
OM - Oman 2
SI - Slovenia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
GY - Guiana 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
Totale 17.375
Città #
Southend 725
Ashburn 662
Milan 603
Singapore 511
Fairfield 507
Santa Clara 472
Rome 391
Chandler 315
Hong Kong 299
Woodbridge 252
Seattle 215
Houston 212
San Jose 196
Cambridge 178
Wilmington 164
Naples 146
Modena 143
Hefei 126
London 124
Council Bluffs 123
Beijing 120
Nyköping 119
Turin 117
Ho Chi Minh City 102
Bologna 97
Florence 93
New York 92
Los Angeles 91
Ann Arbor 86
Dearborn 82
The Dalles 78
Chicago 76
Hanoi 73
Seoul 59
Catania 56
Genoa 56
Palermo 54
Jacksonville 51
Helsinki 50
Bari 48
Lauterbourg 48
Jakarta 47
Verona 47
Parma 46
Moscow 42
San Diego 42
Pescara 39
Shanghai 36
Cagliari 35
Dallas 34
Princeton 32
São Paulo 32
Sofia 31
Salt Lake City 28
Zurich 28
Mexico City 25
Orem 25
Redwood City 25
Tokyo 25
Buffalo 24
Como 23
Munich 23
Warsaw 23
Amsterdam 21
Eugene 21
Brescia 20
Frankfurt am Main 20
L’Aquila 20
Dublin 19
Elk Grove Village 19
Chennai 18
Fremont 18
Messina 18
Paris 18
Phoenix 18
Atlanta 17
Padova 17
Ventimiglia 17
Bergamo 16
Dalmine 16
Monza 16
Tampa 16
Toronto 16
Brasília 15
Bremen 15
Da Nang 15
Haiphong 15
Manchester 15
Perugia 15
Philadelphia 15
Reggio Emilia 15
Boston 14
Düsseldorf 14
Lucca 14
Trento 14
Dong Ket 13
Istanbul 13
Rio de Janeiro 13
Ancona 12
Dolianova 12
Totale 9.324
Nome #
Correlazione tra fumo di cannabis e pneumotorace spontaneo. 6.862
Allopregnanolone serum levels in female migraineurs 790
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017 670
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair 510
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study 423
Monitoring of adherence to headache treatments by means of hair analysis 397
Medication overuse and chronic migraine: a critical review according to clinical pharmacology 396
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS 384
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 358
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs 342
A case-control study of visually evoked postural responses in childhood with primary headaches 309
Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache 302
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study 284
Secondary spontaneous pneumothorax and bullous lung disease in cannabis and tobacco smokers. A case-control study. 263
Polypharmacy Among Headache Patients: A Cross-Sectional Study 262
Hair testing as a marker of adherence to headache treatments 252
Glutamate receptor antagonists with the potential for migraine treatment 251
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 250
Proteomic serum profile in menstrual-related and post menopause migraine 250
Serum changes of apolipoproteins in Medication Overuse Headache (MOH) 248
Erenumab per il trattamento preventivo dell'emicrania cronica: efficacia e sicurezza fino a un anno, predittori di risposta ed effetti della sospensione. 244
Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review 241
Oral Cannabinoid Preparations for the Treatment of Chronic Migraine: A Retrospective Study 233
Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive age 229
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache 225
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 213
Proteomic serum profile of female migraineurs 211
Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study 201
Visually Evoked Postural Responses (VEPRs) in Children with Vestibular Migraine 182
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data 182
Occlusal splint therapy in patients with Ménière’s disease and temporomandibular joint disorder 177
Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic 172
Topical Cannabidiol in the Treatment of digital ulcers in patients with Scleroderma: comparative Analysis and Literature Review 168
OnabotulinumtoxinA: Still the Present for Chronic Migraine 153
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 153
Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real-world clinical evidence in a severely impaired patient population 152
Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study 146
Monoclonal anti-CGRP antibodies in post-menopausal women: a real-life study 134
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study 108
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study 105
Correction to: Monoclonal anti‑CGRP antibodies in post‑menopausal women: a real‑life study (Acta Neurologica Belgica, (2023), 123, 3, (1039-1047), 10.1007/s13760-023-02190-5) 99
Totale 17.531
Categoria #
all - tutte 47.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.822


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 0 0 108
2021/20221.367 123 64 114 138 48 79 64 116 127 117 220 157
2022/20232.537 166 191 187 224 189 230 188 229 305 139 252 237
2023/20242.547 212 213 227 207 265 193 238 221 160 185 225 201
2024/20253.140 178 151 145 267 432 385 259 206 333 195 279 310
2025/20264.009 332 170 260 540 751 247 506 196 362 369 228 48
Totale 17.531